Their Phase 2a clinical trial of Hoth's topical gel HT-001 has shown 100% success in combating skin toxicities caused by ...

Since 2023, seven babies in the neonatal intensive care unit of a Richmond hospital have suffered unexplained fractures and ...

Tumor cells circulating in the blood are the "germ cells" of breast cancer metastases. They are very rare and could not be propagated in the culture dish until now, which made research into therapy ...

Dec. 9, 2024 — Researchers used lab-grown organoids created from tumors of individuals with glioblastoma (GBM) to accurately model a patient's response to CAR T cell therapy in real time.

About Cogent Biosciences, Inc. Cogent Biosciences is a biotechnology company focused on developing precision therapies for genetically defined diseases. The most advanced clinical program, ...

Over the last 7 days, the United States market has remained flat, yet over the past 12 months, it has risen by an impressive 24%, with earnings expected to grow by 15% per annum in the coming years.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Plasmacytoid dendritic cells (pDC) primarily function as weak antigen-presenting cells (APC), but have also been shown to ...

Jan. 3, 2025 — Much of our knowledge of the protein PD-1, a leading cancer treatment target, comes from studies in mice. In a comprehensive assessment of PD-1, ... Enzyme Promoting Tumor Growth ...

eLife is a non-profit organisation inspired by research funders and led by scientists. Our mission is to help scientists accelerate discovery by operating a platform for research communication that ...

The corticotropic-releasing hormone enhances the bone-marrow homing and engraftment of human haematopoietic stem and progenitor cells via the mechanical remodelling of the cell’s cytoskeleton ...